There is still time to register for the Rand Corporation’s latest symposium: Opioid Litigation: What’s New and What Does It Mean for Future Litigation? The virtual event will be held on October 22nd from 12pm (ET) to 4pm (ET) where industry experts such as Sheila Birnbaum (Partner, Dechert LLP), Deborah Hensler (Judge John W. Ford Professor of Dispute Resolution, Stanford Law School), Kenneth R. Feinberg (Founder and Managing Partner, The Law Offices of Kenneth R. Feinberg, PC) and Robert Reville (Praedicat) discuss the ongoing opioid litigation. During their panels the experts will answer the following questions: why is the opioid litigation different? What might these differences mean for the future? What further research is needed to address these new challenges, and many more.
Praedicat CEO, Bob Reville will be presenting during the 1:35pm panel: What’s the Next Opioids?
Although the opioid litigation has yet to be resolved, many insurers, corporations, attorneys and judges are already concerned about “the next opioids”. This panel will address how the legal innovations discussed in the previous panel might play out going forward. What does the future look like for environmental torts and other public health litigation such as climate change or sugar sweetened beverages? The panel will also examine how opioid litigation may change the way in which litigation can be used in the future to address widespread social harms.
Register for the event here.
Missed our webinars about emerging risks and COVID-19? Watch the first Carrier Management ExecTalk video featuring Praedicat, the Praedicat-Intelligent Insurer webinar on the future of risk management, and the first and the second episode of Coffee with Bob now!
Have questions? Get in touch with one of our Account Management team members.